Moreover, IPA analysis demonstrated that the genes disrupted by rare CNVs in the studied breast cancer cases formed a network centered on TP53 and β-estradiol, a notion confirmed in two independent cohorts. The gene discussed is TP53; the disease is breast carcinoma.